Exonhit Receives € 1.93 Million from OSEO within the Personalized Medicine TEDAC Project in Cancer
PARIS--(BUSINESS WIRE)--Regulatory News: Exonhit (Paris: ALEHT) announced today that it has been granted € 1,928,000 by OSEO, as part of its involvement in a consortium led by ERYTECH Pharma and ...
In the presence of French president, Francois Hollande, Francois Drouin, OSEO's CEO and vice-president of the BPI (Banque Publique d'Investissement), announced to Philippe Genne, Oncodesign's CEO and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results